PCN70 ECONOMIC EVALUATION ON THE USE OF PLERIXAFOR ALONGSIDE THE GRANULOCYTE-COLONY STIMULATING FACTOR (GCSF) IN PREPARATION FOR AN AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION ON PATIENTS WITH NON HODGKINS LYMPHOMA
May 1, 2010, 00:00
10.1016/S1098-3015(10)72159-8
https://www.valueinhealthjournal.com/article/S1098-3015(10)72159-8/fulltext
Title :
PCN70 ECONOMIC EVALUATION ON THE USE OF PLERIXAFOR ALONGSIDE THE GRANULOCYTE-COLONY STIMULATING FACTOR (GCSF) IN PREPARATION FOR AN AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION ON PATIENTS WITH NON HODGKINS LYMPHOMA
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)72159-8&doi=10.1016/S1098-3015(10)72159-8
First page :
Section Title :
Open access? :
No
Section Order :
741